Award details

Generation of new natural and non-natural lantibiotics by genome mining and pathway engineering

ReferenceAPG20592
Principal Investigator / Supervisor Professor Michael Gasson
Co-Investigators /
Co-Supervisors
Institution Quadram Institute Bioscience
DepartmentFood Safety Science Division
Funding typeResearch
Value (£) 116,568
StatusCompleted
TypeResearch Grant
Start date 01/01/2004
End date 31/12/2005
Duration24 months

Abstract

The objectives of this proposal are to combine genomic approaches to the discovery and characterisation of multiple lantibiotic gene clusters with genetic manipulation of the known gene cluster for cinnamycin to facilitate the generation of variant class B lantibiotics. The important cinnamycin class will be studied because of its potential therapeutic relevance and the presence of a number of natural variants which allows the control of specificity to be investigated. The therapeutic value of cinnamycin and artificial variants will be evaluated. (Joint with grant 20592)

Summary

unavailable
Committee Closed Committee - Genes & Developmental Biology (GDB)
Research TopicsX – not assigned to a current Research Topic
Research PriorityX – Research Priority information not available
Research Initiative LINK: Applied Genomics (APG) [2000-2004]
Funding SchemeX – not Funded via a specific Funding Scheme
terms and conditions of use (opens in new window)
export PDF file